Two seminars hosted by Duke's Ion Channel Research Unit
Duke's Ion Channel Research Unit invites faculty and trainees to the following seminars:
Wednesday, Sept. 30, 2015
4 p.m.; 143 Jones
Geoffrey Pitt, MD, PhD, Professor of Medicine (Cardiology), Pharmacology and Cancer Biology, Director, Ion Channel Research Unit, Duke University
"Ion channel (dys)regulation and cardiac disease"
Heart Center to mark 40 years of Duke University’s Preventive Approach to Cardiology with Sept. 25 seminar
Duke Heart Center will celebrate the 40th anniversary of Duke University’s Preventive Approach to Cardiology with an afternoon symposium on Fri., Sept. 25, 2015 in the Trent Semans Center for Health Education.
Warraich, cardiovascular diseases fellow, writes about caring for patients with heart failure in New York Times
First-year cardiovascular diseases fellow Haider Javed Warraich, MD, writes about failing patients with heart failure in an opinion piece in today's New York Times.
Ginsburg to speak at White House precision medicine event
Geoffrey Ginsburg, MD, PhD, professor of medicine (Cardiology) and director of the Center for Applied Genomics and Precision Medicine, will speak at the White House’s Champions of Change for Precision Medicine event today.
"I was asked to give one of five presentations to speak about platforms that engage patients for precision medicine," said Dr. Ginsburg. will announce plans to make the MeTree family medical history software widely available.
Ginsburg is a member of the President's Precision Medicine Initiative.
Research: Fewer Than 1 in 10 Older Heart Patients Get Life-Saving Defibrillators
Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a Duke Medicine study published in the Journal of the American Medical Association (JAMA). But fewer than 1 in 10 eligible patients actually get a defibrillator within a year of their heart attacks, the study found.
Peterson quoted in NYTimes feature on drop in deaths from heart disease
Eric Peterson, MD, professor of medicine and executive director of the Duke Clinical Research Institute, was quoted in the New York Times in a front-page story about the nationwide quality movement in the management of acute myocardial infarction.
Spencer, Duke alum, makes $1 million gift to Cardiology
Dr. and Mrs. William H. Spencer, III have made a $1 million bequest in honor of Dr. Spencer’s upcoming Duke School of Medicine reunion, announced Magnus Ohman, MD, vice chair for development and innovation.
Duke cardiologists complete successful implant of new WATCHMAN device
Duke University Medical Center was selected to be an early adopter site, along with two other institutions in NC (UNC and the Sanger Clinic), to implant the WATCHMAN device, which is intended to physically occlude the left atrial appendage and reduce the risk of thromboembolic stroke.
Hernandez to lead PCORnet demonstration study on best aspirin dose to protect patients with heart disease
Adrian Hernandez, MD, MHS, associate profess or medicine (Cardiology), will lead the first randomized clinical trial conducted for PCORnet, the National Patient-Centered Clinical Research Network.
The Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) study will assess whether low- or standard-dose aspirin is better for preventing heart attacks and stroke in patients with coronary artery disease.
Four from Medicine recognized at Spring Faculty Meeting
At the School of Medicine's Spring Faculty Meeting on May 5, the following Medicine faculty were honored with awards:
Michael Blazing, MD, associate professor of medicine (Cardiology), received the Arnold P. Gold Foundation Leonard Tow Humanism in Medicine Award, which recognizes compassion and sensitivity in the delivery of healthcare.